Description
BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR. NDC: 00713-0897-04. P00001 IS TO ADD FUNDS. P00002 IS TO DE-OBLIGATE FUNDS.
Base award description: BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR. NDC: 00713-0897-04.
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-02-02+$3,365= $3,365
- Mod P000012026-05-12+$101= $3,466
- Mod P000022026-09-03-$1,386= $2,080
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-02-02 | +$3,365 | $3,365 | BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR. NDC: 00713-0897-04. |
| Mod P00001· FUNDING ONLY ACTION | 2026-05-12 | +$101 | $3,466 | BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR. NDC: 00713-0897-04. P00001 IS TO ADD FUNDS. |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2026-09-03 | −$1,386 | $2,080 | BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR. NDC: 00713-0897-04. P00001 IS TO ADD FUNDS. P00002 IS TO DE-OBLIGATE… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HDQFPZ3SBV24)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026F0668 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $10,398 | FY2026 |
| 36C26026F0379 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $3,466 | FY2026 |
| 36C24526N0726 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $6,932 | FY2026 |
| 36C25926P0553 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $3,439 | FY2026 |
| 36C24526N0685 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $6,932 | FY2026 |
| 36C25926P0526 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $1,146 | FY2026 |
Other recipients under 6505 from 252-NETWORK CONTRACT OFFICE 12 (36C252) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25226N0551 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $2,100 | FY2026 |
| 36C25226N0550 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $2,500 | FY2026 |
| 36C25226N0549 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $170 | FY2026 |
| 36C25226N0548 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $10,000 | FY2026 |
| 36C25226N0450 | BOSTON SCIENTIFIC CORP | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $607,804 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25226F0127_3600_36F79720D0191_3600 · retrieved 2026-09-26.